Chlorogenic acid protects paraoxonase 1 activity in high density lipoprotein from inactivation caused by physiological concentrations of hypochlorite

Fitoterapia

Volumn 80, Issue 2, 2009, Pages 138-142

  Gugliucci, Alejandro ^a   Bastos, Deborah H Markowicz ^b  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chlorination; Chlorogenic acid; Chlorotyrosine; Ilex paraguariensis; Myeloperoxidase; Polyphenols

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CAFFEOYLQUINIC ACID; CHLOROGENIC ACID; HIGH DENSITY LIPOPROTEIN; HYPOCHLORITE; QUINIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; PRIORITY JOURNAL;

ARYLDIALKYLPHOSPHATASE; CHLOROGENIC ACID; COFFEE; HUMANS; HYPOCHLOROUS ACID; ILEX PARAGUARIENSIS; LIPOPROTEINS, HDL; PLANT EXTRACTS; PROTECTIVE AGENTS;

ILEX PARAGUARIENSIS;

EID: 60349098729     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2009.01.001     Document Type: Article

References (23)

1. Klebanoff S.J. Myeloperoxidase: friend and foe. J Leukoc Biol 77 (2005) 598
2. Heinecke J.W. The role of myeloperoxidase in HDL oxidation and atherogenesis. Curr Atheroscler Rep 9 (2007) 249
3. Lau D., and Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111 (2006) 16
4. Shao B., Oda M.N., Oram J.F., and Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol 21 (2006) 322
5. Oram J.F., and Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85 (2005) 1343
6. Deakin S., Moren X., and James R.W. HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity. Arterioscler Thromb Vasc Biol 27 (2007) 1146
7. Gugliucci A. Hypochlorous acid is a potent inactivator of human plasminogen at concentrations secreted by activated granulocytes. Clin Chem Lab Med 46 (2008) 1403
8. Aviram M. HDL-associated paraoxonase 1 (PON1) and dietary antioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development. Pathophysiol Haemost Thromb 35 (2006) 146
9. Mackness B., Quarck R., Verreth W., Mackness M., and Holvoet P. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler Thromb Vasc Biol 26 (2006) 1545
10. Rosenblat M., Gaidukov L., Khersonsky O., Vaya J., Oren R., Tawfik D.S., et al. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 281 (2006) 7657
11. Khersonsky O., and Tawfik D.S. The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J Biol Chem 281 (2006) 7649
12. Clifford M.N. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J Sci Food Agric 79 (1999) 362
13. Clifford M.N. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med 70 (2004) 1103
14. Fiuza S.M., Gomes C., Teixeira L.J., da Cruz M.T.G., Cordeiro M.N.D.S., Milhazes N., et al. Phenolic acid derivatives with potential anticancer properties - a structure-activity relationship study. Part 1: Methyl, propyl and octyl esters of caffeic and gallic acid. Bioorg Med Chem 12 (2004) 3581
15. Olthof M.R., Hollman P.C., and Katan M.B. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131 (2001) 66
16. Malle E., Furtmuller P.G., Sattler W., and Obinger C. Myeloperoxidase: a target for new drug development?. Br J Pharmacol 152 (2007) 838
17. Lau D., and Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111 (2006) 16
18. Shao B., Oda M.N., Oram J.F., and Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol 21 (2006) 322
19. Kono Y., Shibata H., Kodama Y., Ueda A., and Sawa Y. Chlorogenic acid as a natural scavenger for hypochlorous acid. Biochem Biophys Res Commun 217 (1995) 972
20. Monteiro M., Farah A., Perrone D., Trugo L.C., and Donangelo C. Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 137 (2007) 2196
21. Bixby M., Spieler L., Menini T., and Gugliucci A. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci 77 (2005) 345
22. Bastos D.H.M., Oliveira D.M., Matsumoto R.L.T., Carvalho P.O., and Ribeiro M.L. Yerba maté: Pharmacological Properties, Research and Biotechnology. Med Aromat Plant Sci Biotechnol 1 (2007) 37
23. Schinella G., Fantinelli J.C., and Mosca S.M. Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism. Clin Nutr 24 (2005) 360